Business Wire

Momcozy Introduces the Revolutionary M5 All-in-one Hands-free Breast Pump - Empowering Busy Moms with the Ultimate Maternity Solution

8.6.2023 23:00:00 EEST | Business Wire | Press release

Share

Momcozy, the esteemed maternity and baby brand favored by over two million moms worldwide, proudly unveils the revolutionary M5 all-in-one hands-free breast pump. Designed to provide the ultimate pumping experience for busy breastfeeding moms, this cutting-edge device showcases Momcozy's commitment to meeting the needs of mothers worldwide.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230608005079/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

M5 All-in-one Handsfree Breast Pump (Graphic: Business Wire)

Renowned for its position as a leader in the North American electric breast pump market, Momcozy distinguishes itself yet again with the M5 all-in-one hands-free breast pump. Driven by a user research team that believes in "cozy designs born from love" and strives to cater to customer needs, Momcozy has conducted extensive interviews with thousands of mothers over the past two years.

The team's latest findings highlight "comfort" as the most frequently mentioned requirement among breastfeeding moms, which has significantly influenced the design of the M5 wearable breast pump.

The M5 all-in-one handsfree breast pump stands apart with its unique baby mouth-shaped design, featuring a soft silicone flange set at a precise angle of 105 degrees. By closely imitating the natural suckling position of a baby, it minimizes the risk of nipple pain and discomfort, ensuring a comfortable pumping experience.

Setting new standards in convenience, the M5 all-in-one hands-free breast pump introduces an exclusive vibration suction mode that stimulates milk flow and enhances the overall pumping process. Combining the power of suction and vibration, this feature allows for swift and efficient milk extraction, enabling moms to pump quickly and comfortably.

Additionally, its discreet size enables moms to use it inconspicuously, without drawing attention or hindering their activities, thereby ensuring productivity throughout the day.

To complement its functionality, the M5 all-in-one hands-free breast pump comes with a trendy hard-shell storage bag to cater to the needs of busy moms who are always on the move. Delighted customers have praised the bag for its excellent protection of the breast pumps and parts. The M5 all-in-one hands-free breast pump set includes two breast pumps and all the necessary accessories, including different sizes of flanges, ensuring moms can commence using the breast pump as soon as they receive it. As one satisfied mom noted, "the set offers everything you need altogether."

In a recent survey among women currently or recently using a breast pump, portability, low weight, fast milk extraction, and comfort were rated as crucial factors, with low noise and discreetness also important to younger mothers. By addressing these needs, Momcozy's wearable breast pump has consistently ranked as the top seller. Momcozy places great importance on research and development, guaranteeing that its products are of the highest quality and perfectly aligned with the needs of breastfeeding mothers. That’s why the M5 all-in-one hands-free breast pump emerges as the ultimate solution for busy moms seeking to provide their babies with breast milk while effectively managing their work-life balance.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Marketing Dept.
Joanna Tsai
pr@momcozy.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Linnea Achieves CEP Certification for Cannabidiol Isolate3.3.2026 09:25:00 EET | Press release

Linnea is proud to announce that its Cannabidiol (CBD) Isolate has been granted a Certificate of Suitability to the European Pharmacopoeia (CEP). The CEP serves to attest that the quality of an active pharmaceutical ingredient (API) is adequately controlled by the monographs of the European Pharmacopoeia, ensuring its safety, quality and conformity for use in medicinal products in Europe. Issued by the European Directorate for the Quality of Medicines & HealthCare (EDQM), the CEP represents an independent validation of consistency, safety, and regulatory compliance for the European market. This consequently simplifies the marketing authorization (MA) process for new medicines, as a detailed evaluation of the active substance by regulatory authorities is not required. This milestone represents a significant achievement for the company and reinforces its commitment to delivering consistent and high-quality cannabinoid ingredients. The certification provides customers and partners with as

Quectel Expands Small Cell Antennas Portfolio With Five New Products3.3.2026 09:00:00 EET | Press release

Quectel Wireless Solutions, a global end-to-end IoT solutions provider, has introduced five new small cell antennas to add further functionality and provide greater flexibility and choice for customers designing and implementing small cell deployments. The new antennas bring an additional range of form factors, mounting options and performance characteristics to the Quectel antenna range. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260302915004/en/ Quectel expands small cell antennas portfolio with five new products “Whether you’re looking for an antenna to support critical wireless communications, dense stadium usage scenarios or ultimate capacity, these five new Quectel antennas have been designed to meet your needs,” says David Wei, Antenna Product Head, Quectel Wireless Solutions. “The new antennas augment our already comprehensive range of antennas, bring further choice and add capabilities for developers and enginee

Quectel Introduces FGH200M Wi-Fi HaLow Module for massive IoT Deployments3.3.2026 09:00:00 EET | Press release

Quectel Wireless Solutions, a global end-to-end IoT solutions provider, today announces the launch of the FGH200M long range, low power Wi-Fi HaLow module. Based on the Morse Micro MM8108 chipset and operating in the sub-1GHz license exempt frequency band, the module delivers enhanced penetration and broader coverage, over a range of approximately 1km, while supporting low power consumption and large-scale device connectivity. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260302200601/en/ Quectel introduces FGH200M Wi-Fi HaLow module for massive IoT deployments The FGH200M module adopts the IEEE 802.11ah wireless networking protocol, also known as Wi-Fi HaLow, operating in the license-exempt Sub-1GHz spectrum. Designed to meet the evolving requirements of IoT connectivity, the FGH200M delivers extended Sub-1GHz signal coverage, enabling reliable device control at distances of up to one kilometer. “We’re excited to unveil th

Meiji Seika Pharma’s Morcamilast (ME3183) was Granted Orphan Medicinal Product Designation by the European Commission for Palmoplantar Pustulosis3.3.2026 03:00:00 EET | Press release

Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, President and Representative Director: Toshiaki Nagasato) today announced that morcamilast (proposed international nonproprietary name; development code: ME3183), a selective phosphodiesterase-4 (PDE4) inhibitor, has been granted orphan medicinal product designation by the European Commission (EC) for the treatment of palmoplantar pustulosis (PPP). Palmoplantar pustulosis is a chronic inflammatory disease characterized by the development of multiple sterile pustules on the palms and soles. Patients often experience pain and pruritus of the skin, and the condition can be accompanied by nail involvement and joint pain. Because lesions on the palms are visible to others and lesions on the soles can cause pain while walking, daily functioning can be significantly restricted, leading in a substantial reduction in quality of life. PPP has a pathophysiology distinct from psoriasis and pustular psoriasis, and treatment can be challenging, unde

IFF Completed the Divestiture of Soy Crush, Concentrates and Lecithin Businesses2.3.2026 23:15:00 EET | Press release

IFF (NYSE: IFF) today announced that it has successfully completed the previously announced divestiture of its soy crush, concentrates and lecithin businesses to Bunge. This transaction does not include IFF’s soy isolates business. Welcome to IFF At IFF (NYSE: IFF), we make joy through science, creativity and heart. As the global leader in taste, scent, food ingredients, health and biosciences, we’re innovating for the future. Every day, we deliver groundbreaking, sustainable solutions that elevate products people love — advancing wellness, delighting the senses and enhancing the human experience. Learn more at iff.com, LinkedIn, Instagram and Facebook. © 2026 by International Flavors & Fragrances Inc. IFF is a Registered Trademark. All Rights Reserved. View source version on businesswire.com: https://www.businesswire.com/news/home/20260302231096/en/

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye